Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sarepta Therapeutics (NQ: SRPT )

130.66 -0.51 (-0.39%)
Streaming Delayed Price Updated: 2:59 PM EDT, Mar 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,033,230
Open 131.94
Bid (Size) 130.58 (8)
Ask (Size) 130.77 (4)
Prev. Close 131.17
Today's Range 128.71 - 131.94
52wk Range 61.28 - 159.84
Shares Outstanding 87,981,885
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
TD Cowen Maintains Outperform Rating for Sarepta Therapeutics: Here's What You Need To Know
 
Via Benzinga
The Latest Analyst Ratings for Sarepta Therapeutics
 
Via Benzinga

Performance

YTD
+4.66%
+4.66%
1 Month
+7.18%
+7.18%
3 Month
+2.53%
+2.53%
6 Month
+14.71%
+14.71%
1 Year
+61.37%
+61.37%

More News

Read More
Accelerated Approval For Gene Therapies - US Health Regulator Looks To Improve Process
Via Benzinga
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Sarepta Therapeutics, Inc. (SRPT) Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Why did Sarepta Therapeutics Stock Plummet?
Via MarketBeat
Exposures Product Safety
Sarepta Therapeutics' FDA Adcomm Puts Some Risk, With Potential Approval: Analyst
Via Benzinga
Sarepta Crashes On An Unexpected Roadblock For Its Gene Therapy
Via Investor's Business Daily
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Stock Market Diverges Amid Bank Woes, Growth Gains; First Republic, Credit Suisse, Meta In Focus: Weekly Review
Via Investor's Business Daily
Sarepta Plunges As FDA Takes Surprise Turn; AdComm Meeting Set For Duchenne Gene Therapy
Via Benzinga
First Republic Bank, Blend Labs, Purple Innovation And Other Big Stocks Moving Lower On Friday
Via Benzinga
Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Are Crypto Stocks COIN, MARA, RIOT, HUT, MSTR Up Today?
Via InvestorPlace
The 2 Stocks to Watch on a Nail-Biter Friday
Via The Motley Fool
NVDA Stock Price Prediction: Morgan Stanley Issues $304 Price Target for Nvidia Shares
Via InvestorPlace
Why Is Sarepta Therapeutics (SRPT) Stock Down 20% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Sarepta Therapeutics Shares Are Trading Lower By Around 19%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Nasdaq, S&P Futures Dip, Signaling Pause In Rally As Focus Shifts To Next Week's Fed Decision: Analyst Says Brace For More Volatility Near Term
Via Benzinga
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SRPT
From The Rosen Law Firm, P.A.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Sarepta Therapeutics Announces Advisory Committee Meeting will be Held for SRP-9001
From Sarepta Therapeutics, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.